You are here: Home: LCU 1 | 2007: Ronald B Natale, MD: Select publications

SELECT PUBLICATIONS

Fehrenbacher L et al. A phase II, multicenter, randomized clinical trial to evaluate the efficacy and safety of bevacizumab in combination with either chemotherapy (docetaxel or pemetrexed) or erlotinib hydrochloride compared with chemotherapy alone for treatment of recurrent or refractory non-small cell lung cancer. Proc ASCO 2006; Abstract 7062.

Gatzemeier U et al. Phase II trial of single-agent sorafenib in patients with advanced non-small cell lung carcinoma. Proc ASCO 2006;Abstract 7002.

Heymach JV et al. A phase II trial of ZD6474 plus docetaxel in patients with previously treated NSCLC: Follow-up results. Proc ASCO 2006;Abstract 7016.

Hirsch FR et al. Predicting clinical benefit from EGFR TKIs: Not all EGFR mutations are equal. Proc ASCO 2006;Abstract 7072.

Natale RB et al. ZD6474 versus gefitinib in patients with advanced NSCLC: Final results from a two-part, double-blind, randomized phase II trial. Proc ASCO 2006;Abstract 7000.

Socinski MA et al. Efficacy and safety of sunitinib in previously treated, advanced non-small cell lung cancer (NSCLC): Preliminary results of a multicenter phase II trial. Proc ASCO 2006;Abstract 7001.

Table of Contents

Top of Page